Sylvester Comprehensive Cancer Center

E-mail a Friend

Mohammad Jahanzeb, M.D.

General Information

Mohammad  Jahanzeb, M.D.

Languages

  • English
  • Punjabi
  • Urdu

Certifications

  • American Board of Internal Med-Hematology
  • American Board of Internal Med-Medical Oncology

CV

Specialties

  • Hematology/Oncology - Internal Medicine
  • Internal Medicine

Roles

  • Professor of Clinical Medicine, Medical Director, Associate Center Director for Community Outreach

Clinical Interests

 

Breast Cancer and Lung Cancer

Awards

NCCN Board of Producers Award
Gold Medal Award Kemcaana
2009-2014 Castle Connolly America's Top Doctors® and 2005-2007, 2009-2014 Castle Connolly America's Top Doctors® for Cancer
Best Doctors in America
Silver Medal in Final Professional M.B.B.S. (MD)
National Talent Scholarship throughout medical school
Merit Scholarship throughout high school

Education

1990-1993 Fellowship
Barnes Hospital: St. Louis, MO
1988-1990 Residency
New Britain General Hospital: New Britain, CT
1987-1988 Internship
New Britain General Hospital: New Britain, CT
1986 Graduate School
King Edward Medical College: Lahore, Pakistan

Publications

  • 1. Aapro M, Andre F, Blackwell K, Calvo E, Jahanzeb M, Papazisis K, Porta C, Pritchard K, Ravaud A, “Adverse Event Management in Patients With Advanced Cancer Receiving Oral Everolimus: Focus on Breast Cancer” Annals of Oncology 2013
  • Lynch TJ, Brahmer J, Fischbach N, Garst J, Jahanzeb M, Kumar, P, Robles R, Spigel D, Vidaver RM, Wozniak AJ, Fish S, Flick ED, Leon L, Datal D, Kosty MP; “Safety and Effectiveness of Bevacizumab - Containing Treatment for Non-Small Cell Lung Cancer: Final Results of the ARIES Observational Cohort Study” submitted
  • Ettinger DS, Akerley W, Borhhaei H, Chang AC, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Ganti AK, Govindan, R, Grannis, Jr. FW, Horn L, Jahan TM, Jahanzeb M, Kessinger, A, Komaki R, Kong KF, Krs, MG, Krug LM, Lennes IT, Loo, Jr. BW, Martins R, O’Malley J, Osarogiabon RU, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood, DE, Yang SC, Hughes M, Gregory KM; “Non-Small Lung Cancer: “Clinical Practice Guidelines in Oncology”. J Natl Comp Cancer
  • 4. Ettinger DS, Akerley, Jahanzeb M, et.al. “Malignant Pleural Mesothelioma” JNatl Compr Canc Netw. 2012 Jan 1;10 (1):26-41
  • 5. Abulkhair O, Saghi L, Saadedin A, Elzahwary H, Siddiqui N, Al Saleh M, Geara F, Birido N, Al-Eissa N, Sukhun SA, Abdulkareem H, Ayoub MM, Deirawan F, Fayaz S, Kandil A, Khatib S, El-Mistiri M, Salem D, Sayd ek SH, Jaloudi M, Jahanzeb M, Gradishar WI; MENA Breast Cancer Regional Guidelines Committee “Modification and Implementation of NCCN Guidelines on Breast Cancer in the Middle East and North Africa Region”. J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S8-S15.
  • Jazieh AR, Bamefleh H, Demirkazik A, Gaafar RM, Geara FB, Javaid M, Khader J, Omar W, Saadeddin A, Sabe HA, Shadmehr MB, El Sherif A, Uddin N, Jahanzeb M, Ettinger D; MENA Lung Cancer Regional Guidelines Committee “Modification and Implementation of NCCN Guidelines on Non-Small Cell Lung Cancer in the Middle East and North Africa Region. J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S16-21.
  • Johnson PE, Dahlman G, Eng K, Garg R, Gottlieb S, Hoffman JM, Howell P, Jahanzeb M, Johnson S, Mackler E, Rubino M, Sarokhan B, Marc Stewart F, Tyler T, Vose, JM, Weinstein S, Li EC, Demartino J; NCCN Oncology Risk Evaluation and Mitigation Strategies (REMS) Work Group. J Natl Compr Canc Netw. 2010 Sep;8 Suppl 7:S7-S27.
  • Jazieh A, Azim H, McClure J, Jahanzeb M “the Abu Dhabi Declaration: Adapted Application of NCCN Clinical Practice Guidelines in Oncology in the Middle East and North Africa Region” Journal of the National. Comprehensive Cancer Network, 2010 Jul: Volume 8 Supplement 3.
  • Jazieh AR, Azim HA, McClure J, Jahanzeb M. “The process of NCCN Guidelines adaptation to the Middle East and North Africa Region”. J Natl Compr Canc Netw. 2010;8 Suppl 3:S5-7.
  • Abulkhair O, Saghir N, Sedky L, Saadedin A, Elzahwary H, Saddiqui N, Al Saleh M, Geara F, Birido N, Al-Eissa N, Sukhun SA, Abdulkareem H, Ayoub MM, Deirawan F, Fayaz S, Kandil A, Khatib S, El-Mistiri M, Salem D, Sayd el SH, Jaloudi M, Jahanzeb M, Gradishar WI; MENA Breast Cancer Regional Guidelines Committee. “ Modification and Implementation of NCCN Guidelines on Breast Cancer in the Middle East and North African Region. J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S8-S15.
  • Jazieh AR, Azim HA, McClure J, Jahanzeb M, “The Process of NCCN Guidelines Adaptation to the Middle East and North African Region” J Natl Compr Canc Netw. 2010 Jul;8 Suppl 3:S5-7
  • Jazieh AR, Bamefleh H, Demirkazik A, Gaafar RM, Javaid M, Khader J, Khodadad K, Omar W, Saadeddin A, Sabe HA, Shadmehr MB, El Sherif A, Uddin N, Jahanzeb M, Ettinger D,; MENA Lung Cancer Regional Guidelines Committee, “Modification and Implementation of NCCN Guidelines on Non-Small Lung Cancer in the Middle East and North Africa Region”. J Natl Compr canc Netw. 2010;8 Suppl 3:S 16-21.
  • Johnson PE, Dahlman G, Eng K, Garg R, Gottlieb S, Hoffman J, Howell P, Jahanzeb M, et al, “NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: “Recommendations for Stakeholders” Journal of the National Comprehensive Cancer Network, September 2010, Volume 8 Supplement 7.
  • Jazieh A, Azim H, McClure J, Jahanzeb M “The Abu Dhabi Declaration: Adapted Application of NCCN Clinical Practice Guidelines in Oncology in the Middle East and North Africa Region” Journal of the National Comprehensive Cancer Network, 2010 Jul: Volume 8 Supplement
  • Mahtani R, Jahanzeb M “Bisphophonates as anticancer therapy for early breast cancer” Clinical Breast Cancer. 2010 Oct 1;10(5):359-66
  • Ettinger D, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D’Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW Jr, JahanT, Jahanzeb M, et al, “Non-small cell lung cancer.” Journal of the National Comprehensive Cancer Network, 2010 Jul;8(7):740-801.
  • Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Forero A, Giordano SH, Goldstein LJ, Gradishar WJ, Hayes DF, hudis CA, Jahanzeb M, et al, “NCCN Clinical Practice Guidelines in Oncology, Breast Cancer.” National Comprehensive Cancer Network 2010
  • Jahanzeb, M, “Continuing trastuzumab beyond progression” Journal of Clinical Oncology. 2009 Apr 20;27(12):1935-7.
  • Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, Erban JK, Farrar WB, Goldstein LJ, Gradishar WJ, Hayes DF, hudis CA, Jahanzeb M, et al, “Breast Cancer Treatment Guidelines.” J Natl Compr Canc Netw. 2009 Feb;7(2):122-92.
  • Wagman LD, Baird MF, Bennett CL, Bockenstedt PL, Cataland SR, Fanikos J, Fogarty PF, Goldhaber SZ, Grover TS, Haire W, Hassoun H, Hutchinson S, Jahanzeb M, et al, “Venous Thromboembolic Disease
  • Carlson R, Moench S, Hurria A, Balducci L, Burstein H, Goldstein L, Gradishar W, Hughes K, Jahanzeb M, “NCCN Task Force Report: Breast Cancer in the Older Woman”, JNCCN, July 2008, Vol 6 No 4, p 1-27

Biography

 

Mohammad Jahanzeb, MD, FACP, is Professor of Clinical Medicine, Hematology Oncology at University of Miami’s Miller School of Medicine. Dr. Jahanzeb currently serves as the Medical Director of UM Sylvester Deerfield Campus and an Associate Director of Community Outreach for the Sylvester Comprehensive Cancer Center. An international lecturer on issues related to breast and lung cancers, Dr. Jahanzeb has given more than 800 lectures as an invited speaker and has authored or contributed to more than 150 original reports, book chapters, reviews, and abstracts. Dr. Jahanzeb is board certified in internal medicine with subspecialties in hematology and medical oncology. He received his medical degree with high honors from King Edward Medical College at the University of Punjab in Lahore, Pakistan. Dr. Jahanzeb is a fellow of the American College of Physicians and American College of International Physicians, and belongs to several professional societies including the American Society of Clinical Oncology, American College of Physicians, the American Society of Hematology and the International Association for the Study of Lung Cancer. He is the Chair Elect for QOPI Measures Steering Committee for American Society of Clinical Oncology and he is currently a member of the FLASCO Board of Directors and is Chairman of the Program Committee.

 

 

E-mail a Friend